ENDED 31 DECEMBER 2019 3. Financial highlights (based on Thai FRS) Q4 2019 Financial Statement Summary as of 31 December 2019 compared to Q4 2018: Note: Gross profit = Sales and service income – Cost of

service income 232.44 229.27 3.17 1% Other income 3.27 2.00 1.27 64% Total revenues 235.71 231.27 4.44 2% Cost of sales and services 172.62 168.62 4.00 2% Gross profit 59.82 60.65 -0.83 -1% Gross profit

-1.18 -50% Net income for period -1.68 14.96 -16.64 -111% Earnings per share (THB) -0.01 0.05 -0.06 -111% FY 2019 FY 2018 YoY change YoY % change Unit: Million Thai Baht (THB) Sales and service income

) (10.2%) Finance costs (49.6) (65.4) (72.4) 10.7% 46.0% (93.1) (137.9) 48.1% Profit before income tax 342.5 302.6 238.9 (21.1%) (30.2%) 629.5 541.5 (14.0%) Tax expenses (26.8) (47.4) (19.4) (59.1%) (27.6

on dissolution of Solvay Biochemicals (Taixing) Limited amounting to 89 MB from other comprehensive income to the profit of the year 2018. Summary of Performance For the year 2019, the Company and its

Q2/2020 totaled THB 2.6 MB, consisting of administrative expenses for Q2/2020 amounting to THB 8.1 MB and adjusted other income. Due to the profit and loss account on the exchange for the 6 month

- (4.9) (6.8) 38.8% N.A. (1.4) 5.1 N.A. Other income 2.9 4.7 4.9 4.3% 69.0% 22.0 18.2 (17.3%) Profit before expenses 502.1 414.5 269.4 (35.0%) (46.3%) 1,452.9 1,153.6 (20.6%) Administrative expenses (106.9

-0.85 -0.77% 109.88 109.23 0.65 0.59% Profit (Owners of the parent) 9.68 9.48 0.20 2.12% 8.63 12.59 -3.96 -31.46% Total Comprehensive Income for the Period 8.67 6.37 2.30 36.05% In overall the profit of

(MB) 83.9 209.3 -59.9% EBITDA (%) 9.6% 23.0% Earnings per share (Baht) 0.08 0.28 Remark : EBITDA = Profit before finance costs, income tax, Depreciation and Amortization Statement of Income : Million

% Net Profit 1.3% 6.7% EBITDA (MB) 9.0 20.8 -56.9% EBITDA (%) 5.1% 11.7% Earnings per share (Baht) - 0.02 -100.0% Remark : EBITDA = Profit before finance costs, income tax, Depreciation and Amortization